Dominik Selleslag, Stefan Suciu, Giovanna Meloni, Petra Muus, Constantijn J.M. Halkes, Adriano Venditti, Safaa M. Ramadan, Hans Pruijt, Liv Meert, Marco Vignetti, Jean-Pierre Marie, Sébastian Wittnebel, Theo de Witte, Sergio Amadori, Roelof Willemze, and Frédéric Baron. 2017. “Low-Dose Clofarabine in Combination With a Standard Remission Induction in Patients Aged 18–60 Years With Previously Untreated Intermediate and Bad-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome: Combined Phase I/II Results of the EORTC/GIMEMA AML-14A Trial”. Haematologica 102 (2). Pavia, Italy, e47-e51. https://doi.org/10.3324/haematol.2016.153130.